Caxton Associates LLP Takes Position in Kenvue Inc. $KVUE

Caxton Associates LLP bought a new position in shares of Kenvue Inc. (NYSE:KVUE) in the 1st quarter, HoldingsChannel.com reports. The firm bought 3,343,101 shares of the company’s stock, valued at approximately $57,635,000. Kenvue accounts for about 1.3% of Caxton Associates LLP’s portfolio, making the stock its 13th biggest position.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Oak Thistle LLC bought a new position in shares of Kenvue during the fourth quarter valued at $1,563,000. Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Kenvue by 25.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 410,874 shares of the company’s stock worth $7,088,000 after purchasing an additional 84,219 shares during the last quarter. Calamos Advisors LLC grew its stake in shares of Kenvue by 24.1% in the first quarter. Calamos Advisors LLC now owns 3,351,000 shares of the company’s stock worth $57,771,000 after purchasing an additional 651,000 shares during the last quarter. Cohen Capital Management Inc. acquired a new stake in Kenvue in the fourth quarter valued at $2,448,000. Finally, Nomura Asset Management Co. Ltd. increased its holdings in Kenvue by 21.5% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 3,491,548 shares of the company’s stock valued at $60,229,000 after purchasing an additional 618,720 shares during the period. 97.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $17.66, for a total transaction of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.59% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Weiss Ratings raised Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Citigroup decreased their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Wall Street Zen raised Kenvue to a “buy” rating in a research note on Sunday, July 12th. Finally, Barclays upped their target price on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday. Three investment analysts have rated the stock with a Buy rating and thirteen have issued a Hold rating to the company. According to MarketBeat, Kenvue currently has a consensus rating of “Hold” and an average price target of $19.58.

Kenvue Trading Down 1.2%

Shares of Kenvue stock opened at $18.89 on Friday. The firm has a market cap of $36.28 billion, a PE ratio of 22.23, a P/E/G ratio of 1.45 and a beta of 0.47. Kenvue Inc. has a 1 year low of $14.02 and a 1 year high of $22.87. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. The stock has a fifty day moving average price of $18.33 and a 200-day moving average price of $17.91.

Kenvue (NYSE:KVUE) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The firm’s quarterly revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.24 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 27th. Shareholders of record on Wednesday, May 13th were paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.4%. The ex-dividend date was Wednesday, May 13th. Kenvue’s payout ratio is presently 97.65%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.